Market Signal Briefing

Alphabet is already one of the most valuable companies in the world, but it's betting big on being the biggest artificial intelligence (AI) company as well.

This isn't likely to be a particularly controversial take, but right now it looks like Alphabet (GOOG 2.42%) (GOOGL 2.53%), Google's parent company, is looking like it will emerge as the artificial intelligence (AI) leader over the next couple of years.

The reasons why are pretty straightforward.

First, Google Gemini is gobbling up market share and is likely to overtake ChatGPT soon.

Second, Alphabet is working to separate itself from Nvidia for its hardware needs with its Tensor Processing Unit (TPU) chip.

Third, per its latest results, Alphabet is leveraging its considerably greater resources than the competition.

Let's discuss all three to illustrate why Alphabet is positioning itself to become the AI kingpin by the end of 2027.

Image source: Getty Images.

Gemini, Google that for me When OpenAI launched ChatGPT in 2022, it quickly became the leader in the generative AI space simply for lack of competition.

By 2023, competitors like Alphabet, Anthropic, and Meta Platforms had brought their competitors to market, but ChatGPT still held 50% market share in the enterprise large language model (LLM) space.

As reported by Menlo Ventures, in the two years since, ChatGPT fell to 27% market share, Anthropic grew from 12% to 40% market share, and Google's Gemini grew from 7% to 21%.

It's on a trajectory to overtake ChatGPT this year if current trends continue, and then it will be a race to the top between Google and Anthropic. Even then, Google wins.

Not a one-trick pony In addition to Gemini, Alphabet has its own proprietary AI hardware, the TPU, developed in partnership with Broadcom.

I won't get into the weeds technically here, but suffice it to say Alphabet's TPU offers a hardware alternative to Nvidia's GPU. And Anthropic is expanding its use of Alphabet's hardware to the tune of 1 million TPUs.

So, Google even wins from Gemini's main competitor because that competitor will be using a lot of Google's hardware.

Money, money, money Now, on to the $400 billion elephant in the room. Alphabet's biggest edge is that while neither OpenAI nor Anthropic has turned a profit yet, it is already profitable, and its revenue for 2025 exceeded $400 billion. That's a 15% increase over 2024. Net income was up 32% over 2024 to $132.1 billion.

None of that was particularly surprising. Google has been growing and profitable for a long time. What did surprise people was the fact that the company is going to roughly double its capital expenditures in 2026 to $175 billion to $185 billion.

Today's Change

(

-2.42

%) $

-8.00

Current Price

$

323.33

Building data centers isn't cheap, and neither is maintaining them. But Alphabet has way more money to spend on them than just about anyone else -- certainly more than the start-ups.

And if it can hold near its 59.6% gross margin and 32% net and operating margins, I'm not too worried about more spending. Plus, liquid cash to fuel that spending spree will not be a problem. In Q4 2025, the company grew its operating free cash flow 34% to $52.4 billion.

Alphabet is betting big on AI and clearly aiming to dominate the industry. And it has the money, products, and reach to pull it off, by my reckoning.

Give it a look if you want to go big on AI like Alphabet is, and come 2027, we'll see who sits atop the AI throne.

The New York Stock Exchange with a Hims & Hers Health, Inc banner is pictured as a person runs past in the Manhattan borough of New York City, New York, U.S., January 21, 2021. REUTERS/Carlo... Purchase Licensing Rights, opens new tab Read more

SummaryCompaniesFDA on Friday said it would restrict ingredientsNovo, Lilly shares fell after Hims launched the pill on ThursdayHims said the decision followed discussions with stakeholdersFeb 7 (Reuters) - Online telehealth company Hims & Hers (HIMS.N), opens new tab on Saturday reversed course on its launch of a $49 compounded version of Novo Nordisk's Wegovy weight-loss pill after the U.S. Food and Drug Administration said it would take action against it.

"Since launching the compounded semaglutide pill on our platform, we’ve had constructive conversations with stakeholders across the industry. As a result, we have decided to stop offering access to this treatment," the telehealth firm said.

Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.

The FDA said on Friday that it plans to restrict GLP-1 ingredients used in compounded drugs that companies such as Hims and compounding pharmacies have marketed, citing concerns over quality, safety and potential violations of federal law.

The Department of Health and Human Services said it would refer the company to the Department of Justice but did not make clear whether it could quickly halt the sale of the Hims' product, the cheapest GLP-1 therapy on the U.S. market.

Reuters reported on Thursday that Hims would begin offering copies of Novo Nordisk's (NOVOb.CO), opens new tab new Wegovy pill at an introductory price of $49 per month, about $100 less than the brand name.

The news caused a selloff in shares of Novo and rival Eli Lilly (LLY.N), opens new tab, whose own pill is expected to launch in April. The shares recovered some of the losses on Friday after FDA Commissioner Dr. Marty Makary tweeted his concern after the market's close on Thursday.

Hims & Hers did not respond to a Reuters query about whether it would continue selling the compounded semaglutide injection.

Federal action to limit the production of any compounded weight-loss drug would be a win for Novo Nordisk, which has been losing share in the weight-loss market to rival Eli Lilly (LLY.N), opens new tab and telehealth firms like Hims.

Novo and Hims had a partnership in 2025 allowing Hims to sell injectable Wegovy, but the two companies walked away with Novo saying Hims had wrongfully marketed copycats of Wegovy. Hims' CEO Andrew Dudum accused Novo of attempting to control how clinicians at Hims make decisions.

Novo Nordisk and Eli Lilly did not immediately respond to a Reuters request for comment.

Compounding, in which pharmacies mix ingredients for specialized medicines or to copy a drug but at different dosages, has flourished as Americans chase cheaper prices for drugs. The practice is legal under the Federal Food, Drug and Cosmetic Act in certain circumstances.

Hims' compounded drug is not FDA-approved and has not gone through clinical trials to prove efficacy.

Makary said in a statement on Friday that the agency will "use all available compliance and enforcement tools within its authorities to address unsubstantiated claims and associated public health concerns."

Reporting by Anusha Shah and Amina Niasse; Editing by Caroline Humer and Andrea Ricci

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Expense ratios, sector weightings, and risk profiles set these two popular ETFs apart in ways that can shape your portfolio strategy.

Both the Vanguard S&P 500 ETF (VOO +1.95%) and the Invesco QQQ Trust, Series 1 (QQQ +2.11%) are popular, large-cap U.S. equity exchange-traded funds (ETFs), but they take different approaches.

VOO tracks the broad S&P 500, while QQQ tracks the NASDAQ-100, which is more tech-focused. This comparison examines cost, performance, risk, and portfolio composition to help investors determine which option best fits their goals.

Snapshot (cost & size)MetricVOOQQQIssuerVanguardInvescoExpense ratio0.03%0.18%1-yr return (as of Feb. 2, 2026)15.79%20.13%Dividend yield1.13%0.46%Beta (5Y monthly)1.001.15AUM$839 billion$407 billionBeta measures price volatility relative to the S&P 500. The 1-yr return represents total return over the trailing 12 months.

VOO is more affordable on fees with a lower expense ratio than QQQ, and it also offers a significantly higher dividend yield. These factors could make VOO more attractive to fee-conscious or income-focused investors.

Performance & risk comparisonMetricVOOQQQMax drawdown (5 y)-24.53%-35.12%Growth of $1,000 over 5 years$1,853$1,945What's insideQQQ tracks the NASDAQ-100, resulting in a portfolio of 101 holdings with a heavy tilt toward technology (making up 53% of assets), communication services (17%), and consumer cyclical (13%). Its top holdings are Nvidia, Apple, and Microsoft.

By comparison, VOO spreads its assets across 504 stocks in the S&P 500. Technology accounts for 35% of the fund, followed by financial services at 13% and communication services at 11%. Its top holdings mirror QQQ’s, but the broader sector mix may appeal to those seeking more diversification.

For more guidance on ETF investing, check out the full guide at this link.

What this means for investorsVOO and QQQ are both massive funds with long track records, focusing exclusively on large-cap stocks. However, their distinct approaches may appeal to different types of investors.

VOO is the more diversified of the two, tracking the S&P 500 and holding stocks across all market sectors. This diversification helps limit its risk during market downturns, as it’s not as heavily tilted toward any one industry.

QQQ, on the other hand, is much more focused on growth. The majority of the fund is allocated to tech stocks, which can be a double-edged sword. While tech can be lucrative, it’s also notorious for its volatility.

Between these two ETFs, QQQ has experienced more volatility. It has a steeper maximum drawdown and a higher beta, indicating more severe price fluctuations than VOO. However, QQQ has also outperformed VOO in both 12-month and five-year total returns.

The right choice for you will depend on your investing goals. If you’re looking for a more diversified ETF with a stronger history of stability, VOO’s S&P 500 focus could be more appealing. Those who are comfortable with more volatility in exchange for greater growth potential, though, may prefer QQQ.

AMD turned in strong results, but the stock fell as expectations were high.

Advanced Micro Devices (AMD +8.32%) posted strong revenue growth to close out 2025 and issued solid 2026 guidance, but the stock fell as investors were expecting more after the stock had doubled over the past year heading into the fourth-quarter report's release. Meanwhile, investors decided not to give the company credit for an unexpected boost in China revenue that it saw in Q4, which may not repeat.

China provides upside Sales of $390 million worth of graphics processing units (GPUs) to China helped boost AMD's Q4 results. However, the company didn't forecast further sales to the country, outside of $100 million in revenue in Q1, with management calling the situation "dynamic."

Image source: Getty Images.

This helped AMD's data center revenue climb 39% year over year in the quarter to $5.4 billion. Growth was led by both record central processing units (CPUs) sales and accelerating GPU deployments. It said that eight of the 10 largest artificial intelligence (AI) companies are now using its GPUs for their AI workloads.

Client and gaming segment, revenue, meanwhile, jumped 37% to $3.9 billion. Within the segment, client revenue rose 34% to $3.1 billion as it continues to take market share in the PC space, while gaming revenue surged 50% to $843 million. However, the company does expect the semi-custom revenue that helped power its 2025 gaming segment results to fall meaningfully in 2026. AMD's smaller embedded segment, meanwhile, saw revenue edge up 3% to $950 million. The company expects the segment to grow in 2026.

Overall, AMD's Q4 revenue climbed by 34% year over year to $10.27 billion. Gross margin came in at 54%, up 300 basis points from a year ago, helped by the reversal of a write-down on its MI308 chips for China. Adjusted earnings per share rose 40% to $1.53, ahead of the $1.32 consensus.

Looking ahead, AMD guided for Q1 revenue to grow by 32% year over year to $9.8 billion, plus or minus $300 million.

Today's Change

(

8.32

%) $

16.01

Current Price

$

208.51

Should investors buy the dip? While AMD was a victim of high expectations, the company still performed well and appears on track for a strong 2026, especially with it expected to start delivering GPUs to OpenAI in the second half of the year. Meanwhile, it remains the dominant data center CPU provider.

Looking at valuation, AMD stock trades at a forward price-to-earnings (P/E) ratio of 32 times 2026 analyst estimates, but it has a forward price/earnings-to-growth (PEG) ratio of only 0.2 (with under 1 times being considered undervalued). That makes this a stock worth grabbing on this price dip, given its solid long-term outlook as AI infrastructure spending continues to ramp up.

Geoffrey Seiler has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Advanced Micro Devices. The Motley Fool has a disclosure policy.

This fund provides diversified commodity exposure with a systematic approach to inflation-sensitive assets and dynamic gold weighting.

What happenedAccording to an SEC filing dated Feb. 6, 2026, Echo45 Advisors LLC reported a new position in Harbor ETF Trust - Harbor Commodity All-Weather Strategy ETF (HGER +1.58%) for the fiscal fourth quarter ended Dec. 31, 2025. The fund acquired 127,402 shares, with an estimated transaction value of $3.16 million based on average prices for the period. The quarter-end value of the new stake was also $3.16 million, reflecting both the purchase and prevailing market pricing.

What else to knowThis is a new position for Echo45 Advisors LLC, now representing 1.8% of its 13F reportable assets under management as of December 31, 2025.Top holdings after the filing:NYSEMKT:VEA: $22.12 million (12.6% of AUM)NYSEMKT:RSP: $16.18 million (9.2% of AUM)NYSEMKT:VWO: $9.31 million (5.3% of AUM)NYSEMKT:DIA: $7.42 million (4.2% of AUM)NASDAQ:QQQM: $7.37 million (4.2% of AUM)As of February 5, 2026, shares of HGER were priced at $26.50, up 21.5% over the past year, outperforming the S&P 500 by 9.35 percentage points.The fund reported a 6.5% annualized dividend yield as of February 6, 2026.ETF overviewMetricValueAUMN/APrice (as of market close February 5, 2026)$26.50Dividend yield6.54%1-year total return21.5%ETF snapshotInvestment strategy targets efficient diversification across a basket of commodity futures, emphasizing inflation sensitivity and economic significance.Portfolio consists of at least 15 of the 24 most liquid commodity futures, with dynamic gold weighting based on a proprietary scarcity debasement indicator; index rebalanced quarterly.Fund structure utilizes excess return swaps via a Cayman Islands subsidiary to optimize tax efficiency and avoid K-1 forms; expense ratio details not provided.Harbor Commodity All-Weather Strategy ETF (HGER) is designed to provide investors with broad-based commodity exposure, focusing on assets most sensitive to U.S. inflation. The fund employs a systematic approach to select and weight commodity futures, with a rules-based process that dynamically adjusts allocations, particularly to gold, based on prevailing inflationary conditions. Its unique structure and index methodology aim to deliver efficient inflation hedging and diversification benefits within a single ETF vehicle.

What this transaction means for investorsEcho45 Advisors added more than a dozen new positions to its portfolio during the fourth quarter of 2025. The purchase of Harbor Commodity All-Weather Strategy ETF shares was the third-largest new position added during the last three months of the year.

Investors who feel nervous about traditional stocks and bonds often gravitate toward commodities that generally don’t experience the same ups and downs as the overall stock market. The Harbor Commodity All-Weather Strategy ETF’s focus on gold futures made the typically non-volatile ETF a big gainer. If we include dividends received, this ETF has produced a 22.8% return over the past year. Over the past three years, it’s delivered a 46.1% total return.

The Harbor Commodity All-Weather Strategy ETF produced outstanding returns in recent years, but it might not be a great investment for risk-averse investors who aren’t comfortable with a lot of exposure to gold prices. Gold accounts for 40.9% of the ETF’s total holdings.

Cory Renauer has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Vanguard FTSE Developed Markets ETF and Vanguard FTSE Emerging Markets ETF. The Motley Fool has a disclosure policy.

– Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint of non-inferiority compared to the current standard of care, Ocrevus, in reducing disability progression in PPMS –

– Fenebrutinib numerically reduced the risk of disability progression by 12% compared to Ocrevus as early as 24 weeks; additional analysis showed potential benefit in upper limb function –

– Fenebrutinib has the potential to become first-in-class in multiple sclerosis, as an oral, brain-penetrant BTK inhibitor for PPMS and relapsing multiple sclerosis (RMS) –

– Regulatory submission for fenebrutinib in both PPMS and RMS is planned following the Phase III FENhance 1 readout, expected mid first half of 2026 –

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new late-breaking data from the Phase III FENtrepid study showing the investigational Bruton’s tyrosine kinase (BTK) inhibitor fenebrutinib met its primary endpoint of non-inferiority compared to Ocrevus® (ocrelizumab) in reducing disability progression in patients with primary progressive multiple sclerosis (PPMS). Fenebrutinib showed a 12% reduction in the risk of disability progression compared to Ocrevus, the only approved medicine for PPMS, as measured by the time to onset of 12-week composite confirmed disability progression (cCDP12) (hazard ratio [HR] 0.88; 95% confidence interval [CI]: 0.75, 1.03) with curves separating as early as 24 weeks. A consistent treatment effect on cCDP12 was observed across patient subgroups and for the entire treatment duration.

The cCDP12 primary endpoint included the confirmed disability progression (CDP) based on the Expanded Disability Status Scale (EDSS) for functional disability, the timed 25-foot walk (T25FW) for walking speed and the nine-hole peg test (9HPT) for upper limb function. The strongest treatment effect was observed on the risk of worsening on the 9HPT by 26% (HR 0.74; 95% CI: 0.56, 0.98) compared to Ocrevus.

“Fenebrutinib showed a consistent clinical benefit as early as week 24, notably in upper limb function, which is essential for preserving independence and daily functioning,” said Professor Amit Bar-Or, Director of the Center for Neuroinflammation and Neurotherapeutics, Perelman School of Medicine, University of Pennsylvania. “With only one disease-modifying therapy available for people with PPMS, fenebrutinib has the potential to be a high-efficacy, oral treatment option that acts directly in the brain, targeting progressive biology, and may slow disability.”

“Fenebrutinib represents the first potential scientific breakthrough for the PPMS community in over a decade, demonstrating a meaningful clinical benefit in reducing disability progression in a study versus the only approved treatment in PPMS,” said Levi Garraway, M.D., Ph.D., chief medical officer and head of Global Product Development. “We look forward to advancing our regulatory submission following the upcoming readout of our second pivotal RMS study, FENhance 1.”

Additionally, a post-hoc analysis showed that fenebrutinib was superior to Ocrevus on a composite endpoint including two of the three components of cCDP12 (EDSS and 9HPT), with a 22% reduction in risk (HR 0.78; 95% CI: 0.64, 0.95).

Adverse events (AEs) commonly (≥10%) observed in the fenebrutinib group were comparable to Ocrevus: infections (67.0% vs 70.9%), nausea (12.0% vs 7.1%) and hemorrhage (10.2% vs 8.1%). Transient and reversible liver enzyme elevations were observed more often in the fenebrutinib group (13.3% vs 2.9%), and all cases resolved after study drug discontinuation. No Hy’s law cases (an indicator for potential severe liver injury) were observed. Serious AEs were reported in 19.1% of patients receiving fenebrutinib (vs 18.9% on Ocrevus) and led to 4.3% withdrawing from treatment (vs 3.0% on Ocrevus). In the FENtrepid study there were 1.4% fatal cases in the fenebrutinib arm vs 0.2% in the Ocrevus arm, all of which were assessed as unrelated to the study treatment by the investigators and no pattern was observed in timing or cause. Epidemiological studies have shown that fatality rates are higher in people living with MS compared to the general population.1-4

Results were shared today as a late-breaking oral presentation at the Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum 2026 in San Diego, California. These data follow Genentech’s announcement in November 2025 that the FENtrepid study and the first of two Phase III relapsing multiple sclerosis (RMS) studies (FENhance 2) met their primary endpoints. Once the second RMS study (FENhance 1) has read out, which is expected in the first half of 2026, data from all Phase III fenebrutinib trials will be submitted to regulatory authorities.

About the FENtrepid study

FENtrepid is a Phase III multicenter, randomized, double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of fenebrutinib compared with Ocrevus in 985 adult patients with PPMS. Eligible participants were randomized 1:1 to receive treatment with either daily oral fenebrutinib (and placebo matched to intravenous [IV] Ocrevus) or IV Ocrevus (and placebo matched to oral fenebrutinib) for at least 120 weeks.

The primary endpoint is the time to onset of 12-week composite confirmed disability progression (cCDP12). The cCDP incorporates three measures of disability – total functional disability measured by the Expanded Disability Status Scale (EDSS), walking speed measured by the timed 25-foot walk (T25FW), and upper limb function measured by the nine-hole peg test (9HPT). This comprehensive composite endpoint offers greater sensitivity than the EDSS alone, capturing additional aspects of disability and often earlier. Key secondary endpoints include the time to onset of 24-week composite confirmed disability progression (cCDP24), 12-week confirmed disability progression (CDP12) and 24-week confirmed disability progression (CDP24).

Following the double-blind treatment period, patients have the option to enter an open-label extension (OLE) phase, in which all patients receive treatment with fenebrutinib.

About fenebrutinib

Fenebrutinib is an investigational oral, central nervous system (CNS)-penetrant, reversible and non-covalent Bruton’s tyrosine kinase (BTK) inhibitor with an optimized pharmacokinetics (PK) profile and high potency. While most current BTK inhibitors are covalent and irreversible, meaning they form a permanent chemical bond with the enzyme, fenebrutinib binds and then eventually releases the enzyme. These design features may help limit off-target effects.

Fenebrutinib has a selectivity for BTK 130 times greater than other kinases which means that it can bind to its intended BTK target without interfering in other kinases. Fenebrutinib can act throughout the body and also cross the blood-brain barrier into the CNS to target chronic inflammation. It is uniquely designed to target relapsing and progressive biology by inhibiting cells in the immune system known as B cells and microglia. Targeting B cells helps control the acute inflammation that causes relapses, while targeting microglia inside the brain addresses the chronic damage that is thought to drive long-term disability progression.

The fenebrutinib Phase III program includes two similarly designed trials in relapsing multiple sclerosis (RMS) (FENhance 1 and 2) with active comparator teriflunomide and the only trial in primary progressive multiple sclerosis (PPMS) (FENtrepid) in which a BTK inhibitor is being evaluated against Ocrevus.

To date, more than 2,700 patients and healthy volunteers have been treated with fenebrutinib in Phase I, II and III clinical programs across multiple diseases, including multiple sclerosis and other autoimmune disorders.

About Ocrevus® (ocrelizumab)

Ocrevus is a humanized monoclonal antibody designed to target CD20-positive B cells, a specific type of immune cell thought to be a key contributor to myelin (nerve cell insulation and support) and axonal (nerve cell) damage. Ocrevus IV and Ocrevus subcutaneous (SC; marketed as Ocrevus Zunovo® [ocrelizumab hyaluronidase-ocsq] in the U.S.) are the only therapies approved for both RMS (including relapsing-remitting multiple sclerosis [RRMS] and active, secondary progressive multiple sclerosis [SPMS], as well as clinically isolated syndrome [CIS] in the U.S.) and primary progressive multiple sclerosis (PPMS). Both Ocrevus IV and SC are administered every six months. The initial IV dose is given as two 300 mg infusions two weeks apart with subsequent doses given as single 600 mg infusions. Ocrevus SC is given as a single 920 mg subcutaneous injection every six months.

About multiple sclerosis

Multiple sclerosis is a chronic disease that affects more than 2.9 million people worldwide. People with all forms of multiple sclerosis experience disease progression from the beginning of their disease. Therefore, an important goal of treating multiple sclerosis is to slow, stop and ideally prevent progression as early as possible.

Approximately 85% of people with multiple sclerosis have a relapsing form of the disease (RMS) characterized by relapses and also worsening disability over time. Primary progressive multiple sclerosis (PPMS) is a debilitating form of the disease marked by steadily worsening symptoms but typically without distinct relapses or periods of remission. Approximately 15% of people with multiple sclerosis are diagnosed with the primary progressive form of the disease. Until the FDA approval of Ocrevus®, there had been no FDA-approved treatments for PPMS and Ocrevus is still the only approved treatment for PPMS.

About Genentech in neuroscience

Neuroscience is a major focus of research and development at Genentech. Our goal is to pursue groundbreaking science to develop new treatments that help improve the lives of people with chronic and potentially devastating diseases.

Genentech and Roche are investigating more than a dozen medicines for neurological disorders, including multiple sclerosis, spinal muscular atrophy, neuromyelitis optica spectrum disorder, Alzheimer’s disease, Huntington’s disease, Parkinson’s disease and Duchenne muscular dystrophy. Together with our partners, we are committed to pushing the boundaries of scientific understanding to solve some of the most difficult challenges in neuroscience today.

About Genentech

Founded 50 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercializes medicines to treat patients with serious and life-threatening medical conditions. The company, a member of the Roche Group, has headquarters in South San Francisco, California. For additional information about the company, please visit http://www.gene.com.

Indications and Important Safety Information

What are Ocrevus and Ocrevus Zunovo?
Ocrevus and Ocrevus Zunovo are prescription medicines used to treat:

Relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Primary progressive MS, in adults. It is not known if Ocrevus and Ocrevus Zunovo are safe and effective in children.

Who should not receive Ocrevus or Ocrevus Zunovo?
Do not receive Ocrevus or Ocrevus Zunovo if you:

have an active hepatitis B virus (HBV) infection. have had a life-threatening administration reaction to ocrelizumab. have had a life-threatening allergic reaction to ocrelizumab, hyaluronidase, or any of the ingredients of Ocrevus Zunovo. Tell your healthcare provider if you have had an allergic reaction to Ocrevus or Ocrevus Zunovo or any of their ingredients in the past. What is the most important information I should know about Ocrevus and Ocrevus Zunovo?
Ocrevus and Ocrevus Zunovo can cause serious side effects, including:

Infusion reactions (Ocrevus): Infusion reactions are a common side effect of Ocrevus, which can be serious and may require you to be hospitalized. You will be monitored during your infusion and for at least 1 hour after each infusion of Ocrevus for signs and symptoms of an infusion reaction. Injection reactions (Ocrevus Zunovo): Injection reactions are a common side effect of Ocrevus Zunovo, which can be serious and may require you to be hospitalized. You will be monitored for signs and symptoms of an injection reaction when you receive Ocrevus Zunovo. This will happen during all injections for at least 1 hour after your first injection, and for at least 15 minutes after all injections following the first injection. Tell your healthcare provider or nurse if you get any of these symptoms:

Itchy skin Rash Hives Tiredness Coughing or wheezing Trouble breathing Throat irritation or pain Feeling faint Fever Redness on your face (flushing) Nausea Headache Swelling of the throat Dizziness Shortness of breath Fatigue Fast heartbeat Additionally, for Ocrevus Zunovo:

Injection site pain Swelling Redness These infusion and injection reactions can happen during or up to 24 hours after administration. It is important that you call your healthcare provider right away if you get any of the signs or symptoms listed above after each infusion or injection.

Infection: Infections are a common side effect. Ocrevus and Ocrevus Zunovo increase your risk of getting upper respiratory tract infections, lower respiratory tract infections, skin infections, and herpes infections. Serious infections can happen with Ocrevus and Ocrevus Zunovo, which can be life-threatening or cause death. Tell your healthcare provider if you have an infection or have any of the following signs of infection including fever, chills, or a cough that does not go away, or painful urination. Signs of herpes infection include: cold sores, shingles, genital sores, skin rash, pain, and itching. Signs of more serious herpes infection include: changes in vision, eye redness or eye pain, severe or persistent headache, stiff neck, and confusion. Signs of infection can happen during treatment or after you have received your last dose of Ocrevus or Ocrevus Zunovo. Tell your healthcare provider right away if you have an infection. Your healthcare provider should delay your treatment with Ocrevus or Ocrevus Zunovo until your infection is gone. Hepatitis B virus (HBV) reactivation: Before starting treatment with ocrelizumab, your healthcare provider will do blood tests to check for hepatitis B viral infection. If you have ever had hepatitis B virus infection, the hepatitis B virus may become active again during or after treatment with Ocrevus or Ocrevus Zunovo. Hepatitis B virus becoming active again (called reactivation) may cause serious liver problems including liver failure or death. Your healthcare provider will monitor you if you are at risk for hepatitis B virus reactivation during treatment and after you stop receiving Ocrevus or Ocrevus Zunovo. Weakened immune system: Ocrevus or Ocrevus Zunovo taken before or after other medicines that weaken the immune system could increase your risk of getting infections. Progressive Multifocal Leukoencephalopathy (PML): PML is a rare brain infection that usually leads to death or severe disability and has been reported with ocrelizumab. Symptoms of PML get worse over days to weeks. It is important that you call your healthcare provider right away if you have any new or worsening neurologic signs or symptoms that have lasted several days, including problems with: Thinking Eyesight Strength Balance Weakness on 1 side of your body Using your arms or legs Decreased immunoglobulins: Ocrevus and Ocrevus Zunovo may cause a decrease in some types of antibodies. Your healthcare provider will do blood tests to check your blood immunoglobulin levels. Before receiving Ocrevus or Ocrevus Zunovo, tell your healthcare provider about all of your medical conditions, including if you:

have or think you have an infection. See “What is the most important information I should know about Ocrevus and Ocrevus Zunovo?” have ever taken, take, or plan to take medicines that affect your immune system, or other treatments for MS. These medicines could increase your risk of getting an infection. have ever had hepatitis B or are a carrier of the hepatitis B virus. have a history of inflammatory bowel disease or colitis. have a history of liver problems. have had a recent vaccination or are scheduled to receive any vaccinations. You should receive any required ‘live’ or ‘live-attenuated’ vaccines at least 4 weeks before you start treatment with Ocrevus or Ocrevus Zunovo. You should not receive ‘live’ or ‘live-attenuated’ vaccines while you are being treated with Ocrevus or Ocrevus Zunovo and until your healthcare provider tells you that your immune system is no longer weakened. When possible, you should receive any ‘non-live’ vaccines at least 2 weeks before you start treatment with Ocrevus or Ocrevus Zunovo. If you would like to receive any non-live (inactivated) vaccines, including the seasonal flu vaccine, while you are being treated with Ocrevus or Ocrevus Zunovo, talk to your healthcare provider. If you have a baby and you received Ocrevus or Ocrevus Zunovo during your pregnancy, it is important to tell your baby’s healthcare provider about receiving Ocrevus or Ocrevus Zunovo so they can decide when your baby should be vaccinated. are pregnant, think that you might be pregnant, or plan to become pregnant. It is not known if Ocrevus and Ocrevus Zunovo will harm your unborn baby. You should use birth control (contraception) during treatment with Ocrevus and Ocrevus Zunovo and for 6 months after your last dose of Ocrevus or Ocrevus Zunovo. Talk with your healthcare provider about what birth control method is right for you during this time. Tell your healthcare provider if you become pregnant while receiving Ocrevus or Ocrevus Zunovo. are breastfeeding or plan to breastfeed. It is not known if Ocrevus and Ocrevus Zunovo pass into your breast milk. Talk to your healthcare provider about the best way to feed your baby if you take Ocrevus or Ocrevus Zunovo. Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of Ocrevus and Ocrevus Zunovo?
Ocrevus and Ocrevus Zunovo may cause serious side effects, including:

Risk of cancers (malignancies) including breast cancer: Follow your healthcare provider’s instructions about standard screening guidelines for breast cancer. Inflammation of the colon, or colitis: Tell your healthcare provider if you have any symptoms of colitis, such as: Diarrhea (loose stools) or more frequent bowel movements than usual Stools that are black, tarry, sticky or have blood or mucus Severe stomach-area (abdomen) pain or tenderness Liver damage: Ocrevus and Ocrevus Zunovo may cause liver damage. Your healthcare provider will do blood tests to check your liver before you start Ocrevus or Ocrevus Zunovo and while you take Ocrevus or Ocrevus Zunovo if needed. Tell your healthcare provider right away if you have any symptoms of liver damage, such as: yellowing of the skin and eyes (jaundice) nausea vomiting unusual darkening of the urine feeling tired or weak The most common side effects of Ocrevus Zunovo include:

Injection reactions Respiratory tract infections Skin infections These are not all the possible side effects of Ocrevus and Ocrevus Zunovo.

Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088. You may also report side effects to Genentech at (888) 835-2555.

For more information, go to https://www.Ocrevus.com or call 1-844-627-3887.

For additional safety information, please see the full Prescribing Information and Medication Guide for Ocrevus.

For additional safety information, please see the full Prescribing Information and Medication Guide for Ocrevus Zunovo.

References

1 Manouchehrinia A, et al. Mortality in multiple sclerosis: meta-analysis of standardised mortality ratios. J Neurol Neurosurg Psychiatry. 2016;87:324–331.

2 Smyrke N, et al. Standardized mortality ratios in multiple sclerosis: Systematic review with meta-analysis. Acta Neurol Scand. 2021;00:1–11.

3 Scalfari A, et al. Mortality in patients with multiple sclerosis. Neurology. 2013;81:184–192.

4 Kingwell E, et al. Causes that Contribute to the Excess Mortality Risk in Multiple Sclerosis: A Population-Based Study. Neuroepidemiology. 2020;54:131–139

The logo of Swiss drugmaker Roche is seen at its headquarters in Basel, Switzerland January 30, 2020. REUTERS/Arnd Wiegmann/File Photo Purchase Licensing Rights, opens new tab

CompaniesBERLIN, Feb 7 (Reuters) - Swiss pharmaceutical company Roche (ROG.S), opens new tab said on Saturday its experimental multiple sclerosis drug fenebrutinib met the main goal in a late-stage trial in patients with primary progressive multiple sclerosis, a rare form of the disease with few treatment options.

In the Phase III study, fenebrutinib cut the risk of worsening disability by 12% compared with Roche's Ocrevus, the only approved therapy for PPMS, the Swiss drugmaker said.

Keep up with the latest medical breakthroughs and healthcare trends with the Reuters Health Rounds newsletter. Sign up here.

Separation of the treatment curves was seen after 24 weeks, and additional analyses suggested potential benefits in upper-limb function.

PPMS is the least common form of multiple sclerosis and is marked by a steady progression of disability from the outset.

Roche said fenebrutinib was the first experimental therapy in more than a decade to show a reduction in disability progression in a PPMS study.

The company said it plans to submit the drug for regulatory approval once additional Phase III data from a relapsing MS trial are available, which it expects in the first half of 2026.

Reporting by Patricia Weiss, writing by Maria Martinez, editing by Louise Heavens

Our Standards: The Thomson Reuters Trust Principles., opens new tab

Why Trust CoinGape

CoinGape has covered the cryptocurrency industry since 2017, aiming to provide informative insights to our readers. Our journal analysts bring years of experience in market analysis and blockchain technology to ensure factual accuracy and balanced reporting. By following our Editorial Policy, our writers verify every source, fact-check each story, rely on reputable sources, and attribute quotes and media correctly. We also follow a rigorous Review Methodology when evaluating exchanges and tools. From emerging blockchain projects and coin launches to industry events and technical developments, we cover all facets of the digital asset space with unwavering commitment to timely, relevant information.

The Bitcoin price climbed above $70,000 yesterday, just a day after crashing to as low as $60,000. Amid this BTC rebound, experts continue to share their opinions about whether the bottom is in or if there is likely to be another Bitcoin crash. Meanwhile, the ‘Trump insider whale’ is dumping his BTC holdings, a move which could further put selling pressure on the leading crypto. 

Will Bitcoin Crash as the Fear Index Hits June 2022 Lows? Market sentiment remained weak despite Bitcoin’s bounce attempt. The Crypto Fear & Greed Index dropped to 6, its lowest reading since June 2022. That reading indicates extreme fear across the crypto market.

Meanwhile, analyst Ted highlighted a key technical level for Bitcoin’s short-term direction. As per analyst Ted, BTC attempted to reclaim $70,000 but failed. He added that Bitcoin needs to reclaim $70,000 for another 8% to 10% move higher. However, he warned that failure could push BTC back toward this week’s low near $60k.

As per trader James Wynn, Bitcoin is now on its fifth straight red monthly candle, which has never happened before. He said the market has three weeks left to see if the month closes green. Wynn noted he profited heavily from shorting at $120,000 but now says he has turned bullish near $68,000. He also said sentiment has flipped even though, in his words, “nothing has changed, just price.”

Meanwhile, Jeff Parker, CIO at ProCap, said the recent violent Bitcoin sell-off is likely tied closely to Bitcoin ETFs and broader capital market stress. Parker said the next few days will show whether buyers step in and support Bitcoin demand. BitMEX co-founder Arthur Hayes had echoed a similar sentiment earlier in the day, blaming trading activity around BlackRock’s IBIT for the crash earlier this week.

RSI and MACD Show BTC is Bearish Bitcoin’s price structure still shows a strong downtrend. BTC continued posting lower highs and lower lows since the late-2025 peak near $100,000. Notably, the recent sell-off pushed Bitcoin from the $90,000 to $85,000 range down to around $63,000. Meanwhile, the prior $75,000 to $80,000 support zone shifted into resistance.

Source: TradingView

Technical indicators also show weakness. RSI is near 31.57, while the signal line is near 31.65, keeping BTC in oversold territory. MACD readings also are deeply bearish, with MACD near -5,640.93 and the signal line near -3,843.60. The histogram is near -1,797, indicating sustained negative momentum. A sustainable trend reversal would require a strong bullish close above key resistance with improving RSI and MACD convergence.

‘Trump Insider’ Whale Garrett Jin Moves 6,599 BTC to Binance Garrett Jin has transferred 6,599 BTC worth roughly $463 million in total value today. As per Lookonchain data, Jin deposited 5,000 BTC, valued near $351 million, into Binance shortly after an earlier 1,599 BTC deposit worth about $112 million.

These transfers come only five days after Jin faced a full liquidation totaling $250 million after Bitcoin crashed. The transfers to the top crypto exchange came as Bitcoin attempted to stabilize after sharp losses.

It is worth mentioning that Jin was the whale that opened large short positions on Bitcoin about 30 minutes before Donald Trump announced a proposed 100% tariff on China.  After Trump’s tariff announcement, the crypto market dropped sharply, triggering over $19 billion in liquidations.

Meanwhile, Whale Alert reported additional major transactions involving Bitcoin. One transfer moved 799 BTC, worth about $56.1 million, from an unknown wallet to Binance. Another transaction shifted 3,401 BTC, valued near $237.5 million, between two unknown wallets.

📊
No votes yet – Be the first to vote

Hyperliquid’s considering something big. The crypto firm might use its own HYPE tokens as collateral for options trading, though company officials won’t confirm anything yet. Market watchers are buzzing.

The speculation started heating up after internal discussions leaked to industry insiders. HYPE tokens currently trade at $0.85, and that price has been pretty volatile since word got out about the potential collateral use. Trading volumes jumped 20% on February 4 alone, according to CoinMarketCap data. Traders are clearly paying attention. But Hyperliquid isn’t talking much, which has everyone guessing about what comes next.

No official timeline exists.

A company spokesperson said on February 2 that talks about using HYPE as collateral are still in early stages. The rep stressed that market conditions and regulatory stuff will guide any final decision. That statement didn’t really calm anyone down, but it confirmed that Hyperliquid’s brass are definitely thinking about it. Industry insider John Carlson thinks this could set a precedent if it happens. Carlson, who works at Digital Assets Consulting, called token collateral “relatively uncharted territory” with both upside and serious risks.

CEO Elena Martinez tried to ease investor nerves during a February 3 shareholder update. She said any decision would focus on shareholder value and market stability first. Martinez acknowledged the buzz around HYPE’s potential new role but didn’t give specifics about timing or implementation details.

The crypto community can’t agree on whether this move makes sense. Some traders see innovation, while others worry about volatility getting worse. Michael Tan from Crypto Insights pointed out that regulatory uncertainty could create major problems. He thinks Hyperliquid’s choice might depend on how crypto rules evolve in coming months.

Meanwhile, HYPE token activity keeps surging. The volume spike shows traders are positioning themselves for whatever Hyperliquid decides. Market analysts are watching price movements closely, trying to predict how an official announcement might affect token value. The lack of clear guidance from the company has kept many traders cautious about making big bets.

Hyperliquid’s board will meet later this month, and that gathering could be crucial. Directors might address the HYPE token strategy directly during those discussions. Until then, everyone’s waiting for signals about the company’s direction. Financial advisor Sarah Lin warned investors on February 5 to stay alert. “Any shifts in strategy can have immediate impacts on token liquidity and investor confidence,” she said.

Regulators are taking notice too. The UK’s Financial Conduct Authority reportedly asked Hyperliquid for more information about its plans. No formal investigation is happening, but the FCA’s interest shows how complex using digital assets as collateral can be from a regulatory standpoint. Trading platforms aren’t taking chances either.

Binance announced February 6 that it’s ready to implement stabilization measures for HYPE token trading if needed. The exchange wants to keep markets orderly amid all the uncertainty. CFO David Singh reinforced the company’s careful approach during a February 7 webinar. He said token collateral use is being explored but no final call has been made. Singh emphasized that any decision would align with long-term vision and current market conditions.

The options trading market has been growing fast, and using native tokens as collateral could give Hyperliquid a competitive edge. But it’s also risky business. Token values can swing wildly based on market sentiment, which could create problems if HYPE’s price crashes while it’s backing options positions. Some analysts think this risk might outweigh potential benefits.

Other crypto firms are watching Hyperliquid’s moves closely. If the experiment works, copycats will probably follow. If it fails, the whole sector might shy away from similar strategies for years. The stakes are pretty high for both Hyperliquid and the broader crypto options market.

Trading data from the past week shows increased interest in HYPE tokens across multiple exchanges. Daily volume has consistently stayed above normal levels since speculation began. This sustained activity suggests traders believe something significant will happen, even if they don’t know exactly what or when.

Market makers are reportedly adjusting their HYPE token inventory in preparation for potential volatility. Several large trading firms have increased their holdings, while others have reduced exposure to limit risk. The mixed positioning reflects uncertainty about which direction the token might move once Hyperliquid makes its decision public.

HYPE tokens closed Friday’s session at $0.87, up slightly from earlier in the week.

Several competing DeFi platforms have already experimented with native token collateral systems, though with mixed results. Uniswap’s governance token saw similar volatility patterns when collateral rumors surfaced in 2023, ultimately declining 15% after the proposal was shelved.

Major institutional investors including Galaxy Digital and Pantera Capital have reportedly increased their HYPE positions this week. Galaxy’s trading desk alone purchased an estimated 2.3 million tokens between February 5-7, according to blockchain analytics firm Nansen.

Post Views: 1

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

Tether found itself at the center of two big stories this week, one legal and one market-driven, each showing a different side of how stablecoins shape crypto activity.

One story involves a law enforcement request that led to a large freeze of assets. The other shows fresh USDT supply hitting markets during a sharp Bitcoin selloff.

Gambling Ops Busted According to reports, Turkish prosecutors asked for help after tracing crypto funds tied to what they say was an illegal online betting operation.

Tether responded by freezing wallets linked to that probe, blocking movement of roughly $544 million in suspected ill-gotten funds.

Paolo Ardoino, Tether’s CEO, has been quoted as saying the company cooperates with law enforcement and follows compliance procedures in these cases.

Reports say this action sits alongside Tether’s wider record of working with authorities in more than 1,800 cases across 62 countries and has resulted in the freezing of billions in USDT over time.

Total crypto market cap currently at $2.3 trillion. Chart: TradingView Tether’s Role In Law Enforcement Cooperation The freeze adds another example of how stablecoin issuers can act on legal requests that target specific wallet addresses.

Reports note Turkish investigators also sought seizure orders for bank accounts and property connected to the alleged network.

While blockchain records are public, linking addresses to people still depends on data, subpoenas, and cooperation between exchanges and issuers. In this case, that cooperation halted transfers of the flagged tokens before they could move further.

Minting When Markets Fall At the same time, market watchers logged a separate development: Tether minted an additional $1 billion USDT as Bitcoin plunged.

Reports show this mint came while Bitcoin dropped by double digits over a short period and amid more than $2 billion in liquidations across crypto markets.

💵 💵 💵 💵 💵 💵 💵 💵 💵 💵 1,000,000,000 #USDT (999,707,500 USD) minted at Tether Treasuryhttps://t.co/xJD8CP4OGN

— Whale Alert (@whale_alert) February 6, 2026

The newly created USDT appeared mostly on networks like Tron, where a large portion of USDT circulates, and it boosted overall stablecoin liquidity during the selloff.

Traders and desks often use freshly issued stablecoins to cover shorts, rebalance positions, or to provide exchange liquidity — and that helps explain why issuers sometimes increase supply in volatile stretches.

Trading And Enforcement, Side By Side These two events together capture a tension in crypto: stablecoins can provide fast liquidity, but they can also be the subject of legal controls when authorities suspect misuse.

Reports note that while mints do not guarantee a market rebound, they make dollars available in crypto form, and that can change short-term flows. At the same time, freezes show that issuers can be pulled into cross-border probes and asset recovery efforts.

What Comes Next Observers are watching whether the extra USDT supply will steer traders back into Bitcoin or remain parked on exchanges as dry powder.

Meanwhile, the Turkish action raises fresh questions about how regulators, issuers, and analytics firms will coordinate to trace and immobilize suspect funds moving across networks.

The balance between providing market liquidity and meeting legal obligations is getting tested in real time.

Featured image from Unsplash, chart from TradingView

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

20h05 ▪ 4 min read ▪ by Fenelon L.

Summarize this article with:

While the crypto fear index reaches historic highs, Metaplanet’s CEO displays a disconcerting calm. Simon Gerovich brings up Buffett’s philosophy to encourage investors to do exactly the opposite of the crowd: buy when everyone is selling. A bold stance as his company continues accumulating bitcoin despite the storm.

In Brief Metaplanet’s CEO cites Warren Buffett to encourage buying during the current crypto panic. CoinMarketCap’s Fear and Greed Index hits historically low levels, signaling extreme investor fear. Bitcoin hit 60,000 dollars before quickly rebounding to 70,000 dollars. Extreme fear zones have historically coincided with the best market entry points. On February 7, Simon Gerovich shook the crypto community with a striking post. The head of Metaplanet invoked the legendary saying of Warren Buffett: “Be greedy when others are fearful.” A message broadcast at the exact moment CoinMarketCap signaled a plunge of its Fear and Greed Index into the “extreme fear” zone.

This timing is no coincidence. Bitcoin had just flirted with 60,000 dollars, wiping out two years of gains and sowing panic among holders. Massive sell-offs were multiplying, volatility was exploding. 

Yet, Gerovich sees something other than a collapse. His graph accompanying the message reveals a repetitive pattern: every zone of intense terror over the past twelve months coincided with a market low, systematically followed by a vigorous rebound.

This contrarian market analysis is based on solid historical data. Investors who dared to buy during previous panic phases consistently recorded substantial profits. 

Bitcoin itself illustrates this dynamic by quickly reclaiming the 70,000 dollar threshold after testing 60,000 dollars.

Institutional Resilience Amid Turbulence Metaplanet does not just preach. The Japanese company applies its philosophy with determination. It now holds 35,102 BTC in its treasury, placing it among the largest institutional holders in the world. A position assumed despite an average acquisition price exceeding 107,700 dollars.

This strategy weighs on traditional financial markets. Metaplanet’s stock fell 5.56% in Tokyo, reflecting investor nervousness about the company’s crypto exposure. Latent losses are real and significant. But management refuses to capitulate.

Metaplanet’s approach fits into a broader institutional trend. Strategy, the world leader with 713,502 BTC, also maintains its accumulation strategy. Despite 12.4 billion dollars of losses reported in the fourth quarter of 2025, Michael Saylor persists with his famous “HODL.” The company even acquired an additional 855 BTC during the correction.

Its CEO Phong Le specifies that Strategy would hold out until Bitcoin drops to 8,000 dollars before considering restructuring. This confidence reflects a long-term vision that transcends short-term moves. Bitcoin thus becomes a cash management tool rather than a mere speculative asset.

Technical analysis corroborates this outlook. Market cycles show that collective capitulation periods often precede smart accumulation phases. Long-term holders use these windows to strengthen their positions while emotional investors liquidate their assets.

In summary, Metaplanet’s bet on the contrarian strategy crystallizes a clear conviction: markets reward patience and discipline. While extreme fear drives the masses to sell, some strategic actors accumulate silently. An approach that could shape institutional adoption of Bitcoin for years to come.

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

Fenelon L.

Passionné par le Bitcoin, j'aime explorer les méandres de la blockchain et des cryptos et je partage mes découvertes avec la communauté. Mon rêve est de vivre dans un monde où la vie privée et la liberté financière sont garanties pour tous, et je crois fermement que Bitcoin est l'outil qui peut rendre cela possible.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.

The cryptocurrency market in early February 2026 is navigating a phase of high volatility. After a sharp weekend correction, Bitcoin (BTC) is currently stabilizing near $69,480, while Ethereum (ETH) struggles to hold the $2,095 level. In this environment, investors are moving away from speculative hype and toward projects with transparent capital structures and proven development progress.

For those scanning the top crypto presale sector, three projects stand out due to their distinct funding models and technical execution: Zero Knowledge Proof (ZKP), Bitcoin Hyper, and Mutuum Finance.

Zero Knowledge Proof (ZKP): The $100M “Build-First” Model ZKP leads the 2026 presale market by reversing the traditional funding sequence. Instead of raising capital to fund future development, the team deployed over $100 million of internal funds before opening public access.

Strategic Capital Deployment: Core Infrastructure: $20 million invested in a four-layer L1 blockchain (consensus, execution, proof, and storage). Hardware Ecosystem: $17 million for the production and global distribution of Proof Pods, which are already active. Premium Assets: $5 million utilized for domain acquisitions and intellectual property.

This “self-funded” approach eliminates the execution risk typically associated with early-stage projects. ZKP facilitates privacy-focused AI computation, allowing data to be verified without disclosure. Currently in Stage 2 of its 450-day Initial Coin Auction, the daily supply is capped at 190 million tokens, ensuring a fair distribution model where all participants in a 24-hour window receive the same effective rate.

Bitcoin Hyper (HYPER): Scaling BTC with $31M in Funding Bitcoin Hyper has emerged as a frontrunner in the Bitcoin Layer-2 space, having raised approximately $31.17 million as it enters its final presale stages.

The SVM Engine: By integrating the Solana Virtual Machine (SVM) with Bitcoin settlement, HYPER aims to solve the scalability issues that have historically limited BTC’s utility. Staking-Driven Growth: The project offers estimated yields of 40% APY, which has led to a significant portion of the presale supply being locked. This strategy aims to stabilize the token’s market entry by reducing immediate circulating supply. Roadmap Status: Currently in its late-stage presale, the project is moving toward a Q1 2026 mainnet launch, positioning itself as a primary gas and governance token for the emerging Bitcoin DeFi ecosystem. Mutuum Finance (MUTM): $20.4M Raised and Active Testnet Validation Mutuum Finance has surpassed the $20.4 million mark, signaling strong demand for decentralized credit solutions that offer real-world utility.

Technical Milestone: On February 7, 2026, the project confirmed the successful completion of its Roadmap Phase 2, with the V1 Protocol fully activated on the Sepolia testnet. The mtToken Utility: Mutuum’s model uses mtTokens as “value-bearing receipts,” where the token’s ratio increases over time against the underlying asset, providing a unique return mechanism for lenders. Security & Participation: With over 19,000 holders and high security scores from CertiK (90/100) and Halborn, Mutuum is currently in Phase 7 of its presale. Tokens are priced at $0.04, with a confirmed exchange listing price of $0.06.

Final Verdict: Capital Setup vs. Market Readiness The 2026 market reset has made transparency the most valuable asset for any top crypto presale:

ZKP offers the highest degree of readiness with $100 million already spent on functional infrastructure. Bitcoin Hyper demonstrates the power of the traditional raise, with $31 million and a massive L2 community. Mutuum Finance provides the clearest validation path with a live testnet and institutional-grade audits already in place. As global liquidity remains selective, these three projects represent the shift toward “utility-first” investment strategies in the digital asset space.

Official Project Links:

Website): https://zkp.com/ On X: https://x.com/ZKPofficial On Telegram: https://t.me/ZKPofficial This article contains information about a cryptocurrency presale. Crypto Economy is not associated with the project. As with any initiative within the crypto ecosystem, we encourage users to do their own research before participating, carefully considering both the potential and the risks involved. This content is for informational purposes only and does not constitute investment advice.

Market surges and sudden downturns can make or break a crypto investor’s confidence. For those navigating Bitcoin’s rollercoaster price action, the need to understand what truly moves the market is undeniable. Sophisticated research shows that Bitcoin price movement reflects a complex mix of market capitalization, technical indicators, investor sentiment, and global economic conditions, all woven into a decentralized system unlike any traditional asset. Grasping these foundations helps investors anticipate the next move, not just react to it.

Key Takeaways Point Details Market Dynamics Bitcoin's price is influenced by market capitalization, technical indicators, investor sentiment, and external economic conditions. Regularly track multiple factors to inform investment decisions. Halving Events Bitcoin's scarcity, driven by halving events approximately every four years, can lead to price appreciation due to decreased supply. Understanding historical patterns is essential for anticipating market movements. Institutional Involvement The rise of Bitcoin Spot ETFs has made Bitcoin more accessible to institutional investors, increasing market legitimacy and liquidity. Monitoring ETF inflows can provide insights into market sentiment. Regulatory Impact Evolving regulatory frameworks are critical in shaping Bitcoin's market behavior. Stay updated on regulatory changes to better gauge their influence on market valuation and investor confidence. Foundations of Bitcoin Price MovementUnderstanding Bitcoin price dynamics requires examining a complex network of interconnected factors that drive market valuation. Bitcoin price movement is not a simple linear process, but rather a multifaceted phenomenon influenced by technological, economic, and psychological elements.

Researchers have developed sophisticated models to decode these price mechanisms. Advanced machine learning techniques reveal several critical foundations of Bitcoin price fluctuations:

Market Capitalization: Total value of circulating Bitcoins Technical Indicators: Price trends, moving averages, trading volumes Investor Sentiment: Collective market psychology and expectations External Economic Conditions: Global financial markets, regulatory environments The underlying price dynamics emerge from a delicate balance between supply constraints and demand signals. Bitcoin's decentralized nature means traditional financial models struggle to predict its movements precisely. Unlike traditional currencies, Bitcoin operates without central bank intervention, making its valuation more responsive to global market sentiments.

Technological factors play a significant role in price determination. Network activity, mining difficulty, halving events, and blockchain developments can dramatically influence investor perceptions and market valuations.

Pro tip: Track multiple indicators simultaneously and avoid making investment decisions based on any single price driver.

Here's a summary of how different factors uniquely impact Bitcoin's price movement:

Key Factor Unique Influence on Price Typical Investor Response Market Capitalization Sets overall valuation level Signals market maturity Network Activity Reflects blockchain utility Tracked for adoption signals Regulatory Developments Can trigger rapid sentiment change May increase or reduce exposure ETF Inflows Boosts liquidity and legitimacy Often leads to renewed optimism Halving Cycles and Scarcity EffectsBitcoin's unique economic model revolves around its built-in scarcity mechanism, most notably expressed through halving events. These strategic supply reductions occur approximately every four years, fundamentally altering Bitcoin's economic landscape and investor dynamics.

Historical halving analyses reveal critical insights into how these cycles impact Bitcoin's valuation. The key characteristics of Bitcoin halving include:

Reduction of mining rewards by 50% Predictable supply limitation built into Bitcoin's protocol Systematic decrease in new Bitcoin creation Potential price appreciation following supply constraints The halving mechanism represents a revolutionary approach to cryptocurrency economics. By mathematically controlling Bitcoin's supply, the network ensures a predictable and diminishing rate of new coin generation. This stands in stark contrast to traditional fiat currencies, where central banks can arbitrarily print money.

Each halving event introduces significant market dynamics. Miners face reduced block rewards, which can trigger substantial shifts in network participation and mining infrastructure. Economic implications of halving cycles demonstrate how these events simultaneously impact miner profitability and broader market sentiment.

Bitcoin's halving represents a deflationary mechanism that distinguishes it from traditional monetary systems.

Investor psychology plays a crucial role during these cycles. As the supply of new Bitcoins becomes more scarce, market participants often anticipate potential price increases, creating a self-reinforcing expectation loop that can drive valuation.

Pro tip: Monitor historical halving patterns and network metrics to understand potential market movements during upcoming reduction events.

For easy reference, compare traditional market cycles versus Bitcoin halving cycles:

Feature Traditional Markets Bitcoin Halving Cycles Cycle Frequency Unpredictable, varies widely Every ~4 years, predetermined Main Trigger Economic shifts or policy moves Blockchain code, mining rewards Impact on Supply Indirect via central banks Direct supply cut by 50% Effect on Sentiment Mixed, often unclear Usually increases bullishness Institutional Demand and ETF InflowsThe landscape of Bitcoin investment has undergone a dramatic transformation with the emergence of institutional-grade investment vehicles, particularly Bitcoin Spot ETFs. These financial instruments have opened new pathways for mainstream investors to engage with cryptocurrency, fundamentally reshaping market dynamics.

Bitcoin ETF approval impact demonstrates significant shifts in institutional participation. The key developments include:

Increased liquidity for Bitcoin markets Lower barrier to entry for institutional investors Enhanced market legitimacy Reduced transaction complexity for large-scale investments Institutional investors have progressively recognized Bitcoin as a strategic asset class. This recognition stems from Bitcoin's potential as a hedge against traditional market volatility and its demonstrated resilience during complex macroeconomic conditions.

The regulatory landscape has played a crucial role in driving institutional interest. Spot ETF approvals represent a pivotal moment, signaling regulatory comfort and institutional acceptance. Institutional demand resilience continues to demonstrate remarkable stability, even amid global economic uncertainties.

Institutional investment marks a critical inflection point in Bitcoin's journey toward mainstream financial acceptance.

Geopolitical risks and macroeconomic instabilities have paradoxically strengthened Bitcoin's appeal. Institutional investors view cryptocurrency as a potential diversification tool, contributing to its growing portfolio allocation strategy.

Pro tip: Monitor institutional ETF inflow trends as a key indicator of Bitcoin's market sentiment and potential price movements.

Regulatory Changes Shaping Market BehaviorThe cryptocurrency landscape continues to evolve dramatically, with regulatory frameworksplaying an increasingly critical role in shaping Bitcoin's market behavior. Global jurisdictions are developing sophisticated approaches to digital asset governance, balancing innovation with risk management.

Global crypto policy developments reveal several transformative trends across major markets:

Increasing institutional compliance requirements Enhanced transparency mandates Standardized reporting protocols More nuanced tax treatment of digital assets Clearer guidelines for cryptocurrency exchanges The regulatory environment has transitioned from uncertainty to measured acceptance. Governments worldwide are crafting policies that simultaneously protect investors and encourage technological innovation, recognizing cryptocurrency's emerging role in the global financial ecosystem.

Institutional adoption hinges significantly on regulatory clarity. Regulatory frameworks influencing adoption demonstrate how comprehensive guidelines can boost investor confidence and market legitimacy. Spot Bitcoin ETPs, for instance, have gained substantial traction through carefully constructed compliance mechanisms.

Regulatory evolution represents the bridge between traditional finance and digital asset ecosystems.

Geopolitical dynamics continue to influence cryptocurrency regulations. Developed economies are leading the way in creating balanced, forward-thinking regulatory approaches that aim to integrate digital assets into mainstream financial systems while mitigating potential risks.

Pro tip: Stay informed about regulatory changes in key financial jurisdictions, as these developments can significantly impact Bitcoin's market valuation and investor sentiment.

Macroeconomic Trends and Global LiquidityBitcoin's price dynamics have increasingly become intertwined with broader macroeconomic trends, transforming from a niche digital asset to a sophisticated financial instrument sensitive to global economic shifts. The cryptocurrency ecosystem now responds dynamically to complex international monetary conditions.

Macroeconomic factors influencing cryptocurrency reveal several critical interconnections:

Global risk appetite indicators International monetary policy changes Currency exchange rate fluctuations Stock market volatility Geopolitical economic tensions The global liquidity landscape has dramatically reshaped Bitcoin's investment profile. Traditional boundaries between digital and conventional assets are blurring, with cryptocurrency increasingly responding to broader economic signals and investor sentiment across international markets.

Advanced pricing models demonstrate Bitcoin's evolving correlation with macroeconomic indicators. The cryptocurrency has transitioned from an isolated financial instrument to a more integrated asset class, showing nuanced responses to global economic conditions.

Bitcoin represents a new class of financial asset bridging traditional and digital economic paradigms.

Investors now view Bitcoin through a more sophisticated lens, considering its performance within complex global economic frameworks. Monetary policies, international trade dynamics, and geopolitical tensions directly influence cryptocurrency valuation in increasingly predictable patterns.

Pro tip: Monitor central bank monetary policies and global economic indicators as leading signals for potential Bitcoin price movements.

Key Risks and Common Price Volatility TrapsBitcoin's price landscape remains notoriously complex, characterized by dramatic fluctuations that can challenge even experienced investors. Understanding the underlying mechanisms of these price movements requires a nuanced examination of multiple interconnected risk factors.

Cryptocurrency volatility research highlights several critical risk dimensions:

Speculative trading patterns Market manipulation potential Regulatory uncertainty Liquidity constraints Investor sentiment volatility Technological infrastructure risks The volatility ecosystem encompasses far more than simple price swings. Sophisticated investors recognize that Bitcoin's price movements result from intricate interactions between technological, economic, and psychological factors.

Advanced volatility measurement approaches reveal the multifaceted nature of Bitcoin price risks. These models demonstrate how seemingly random price fluctuations often follow complex underlying patterns driven by market psychology and structural market characteristics.

Bitcoin volatility represents a unique financial phenomenon bridging traditional market analysis and emerging digital asset dynamics.

Institutional and retail investors must develop robust risk management strategies that account for Bitcoin's inherent price unpredictability. Understanding these volatility traps requires continuous learning and adaptive investment approaches.

Pro tip: Implement strict risk management protocols, including predetermined stop-loss levels and portfolio diversification, to mitigate potential cryptocurrency market volatility.

Navigate the Complex Drivers Behind Bitcoin's 2026 MarketUnderstanding the intricate factors shaping Bitcoin's price movement such as halving cycles, institutional ETF inflows, and evolving regulatory changes can feel overwhelming. The challenge lies in decoding technical indicators and macroeconomic trends that constantly influence market volatility and investor sentiment. If you want to stay ahead in this dynamic landscape you need timely insights and clear analysis.

Discover everything you need to grasp these critical concepts and make informed decisions on Crypto Daily. We bring you the latest updates on Bitcoin’s price drivers and how global economic shifts impact cryptocurrency prices. Don’t miss out on the advantage of real-time market intelligence and expert breakdowns. Visit Crypto Daily now to unlock the knowledge that powers confident crypto investing and track the key trends shaping 2026 markets.

Frequently Asked QuestionsWhat are the main factors driving Bitcoin price movement?Bitcoin price movement is influenced by several key factors including market capitalization, technical indicators, investor sentiment, and external economic conditions. These components interact to create a multifaceted price dynamic.

How do halving events impact Bitcoin's value?Halving events reduce Bitcoin mining rewards by 50%, creating a predictable supply limitation. This scarcity often leads to increased investor anticipation of price appreciation, impacting market dynamics significantly.

What role does institutional demand play in Bitcoin pricing?Institutional demand, particularly through Bitcoin Spot ETFs, has expanded market liquidity and legitimacy, making it easier for institutional investors to access Bitcoin. This demand can lead to increased price stability and upward momentum.

How can global macroeconomic trends affect Bitcoin's price?Global macroeconomic trends, such as changes in monetary policy and geopolitical tensions, influence investor sentiment and risk appetite. Bitcoin's correlation with these economic indicators suggests that its price can respond dynamically to broader economic changes.

Recommended Crypto Influencers to Watch for the 2026 Market Cycle - Crypto Daily Bybit's 2026 Crypto Outlook Challenges the Four-Year Crypto Cycle - Crypto Daily Bitcoin Price Analysis: Analysts Optimistic Despite BTC’s Crash To $95,000 - Bitzo Bitcoin Price Analysis: BTC Struggling at $91,000 As Analysts Warn Volatility Could Persist - Bitzo Disclaimer: This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

Arthur Hayes, co‑founder of BitMEX, has pointed to hedging tied to BlackRock’s iShares Bitcoin Trust (IBIT) as a major driver behind the recent Bitcoin sell‑off.

According to Hayes, dealer hedging related to IBIT and similar structured products can force large, mechanical selling when markets move against those positions.

Reports note that such moves can amplify a price drop already set off by other pressures.

Heavy Hedges Can Trigger Sudden Selling Pressure: Hayes Hayes argues that banks and dealers who underwrite structured notes and ETF‑linked products often hedge their exposure in the spot and derivatives markets.

Those hedges can be heavy and fast. When a large product faces outflows or redemption triggers, hedges are adjusted quickly. That can translate into sudden selling pressure that pushes prices down further, especially if liquidity is thin.

$BTC dump probably due to dealer hedging off the back of $IBIT structured products. I will be compiling a complete list of all issued notes by the banks to better understand trigger points that could cause rapid price rises and falls. As the game changes, u must as well. pic.twitter.com/9DF8VE9XBL

— Arthur Hayes (@CryptoHayes) February 7, 2026

Market Moves And Liquidity Stress The market behaved like a room of people trying to leave at once. Prices plunged, then bounced. Reports say Bitcoin fell steeply from its recent highs before staging a partial recovery.

Bitcoin has fallen to around $68,500 Saturday, down 16% in the last seven days, data from Coingecko shows.

Trades and order books showed spikes in volume, which is one sign that hedging flows and quick rebalancing were at play. Some analysts say macro news and trader positioning also mattered. The truth likely sits in the overlap of these causes.

Bitcoin is now trading at $68,946. Chart: TradingView Who Bears The Risk Dealers carry risk when they underwrite complex products. In certain moments, that risk is passed back into the market through hedging. That’s how, according to Hayes, a few large issuers can indirectly set off a chain reaction that affects many other holders and traders. The moves can be sudden and mechanical, not always driven by sentiment.

A Watchful Washington Reports say the role of spot ETFs in crypto markets is now on regulators’ and policymakers’ radar. US President Donald Trump’s economic team has been monitoring big flows into and out of institutional vehicles, while market participants debate whether ETFs stabilize prices or add new stress points.

Whatever the view, structured products now form a clear link between traditional finance and crypto volatility.

Broader Takeaways This episode underlines how new financial plumbing can create new channels for contagion. Some see the presence of large, regulated players as a net positive for long‑term adoption.

Others warn those same players introduce conventional market mechanics that can behave unpredictably when stretched. Reports note both perspectives are useful when piecing together why prices moved the way they did.

Who Is Right, And What Next Hayes has laid out a theory that ties observable hedging flows to the crash. It is a compelling thread that fits many of the market signals seen in recent days.

Still, other factors—macro shifts, concentrated profit‑taking, and liquidity gaps—likely played parts as well. Traders will watch flows closely, and structured product issuers will be asked hard questions.

Featured image from Unsplash, chart from TradingView

TLDR: DOGE hits TD Sequential 9, signaling sellers may be exhausted after weeks of downside.  Price finds support near $0.090, creating a potential zone for short-term relief rallies.  RSI and MACD show fading bearish momentum, hinting at early strength returning.  The monthly accumulation range of $0.077–$0.055 could set up DOGE for long-term upside toward $1. DOGE TD Sequential indicates potential trend exhaustion after a persistent downtrend. The completed nine-count setup aligns with key support near $0.090, pointing toward a likely relief bounce or sideways consolidation before the next directional move.

TD Sequential Signals Short-Term Relief DOGE’s daily chart shows a completed TD Sequential buy setup after nine consecutive bearish closes. This occurs at the end of a clear downtrend marked by lower highs and lower closes. 

TD Sequential focuses on trend fatigue rather than strength, making this setup notable. Moreover, price action around the TD 9 marker confirms selling exhaustion. 

The sharp, impulsive sell-off led into the signal, followed by a small-bodied candle with long lower wicks. This indicates that bears pushed hard but failed to hold control. 

Consequently, buyers entered quietly near the $0.095–$0.090 zone, coinciding with prior support levels. Additionally, momentum indicators support the TD read. 

RSI rose from oversold territory into the mid-40s, showing gradual strength. Meanwhile, MACD histogram compression suggests fading bearish momentum. 

Therefore, the setup favors a short-term relief bounce. Furthermore, tweets from market observers emphasize that the 4-hour TD Sequential setup confirms seller exhaustion. 

Price stabilized above $0.090 instead of breaking lower, carving higher intraday lows. As a result, fresh short positions face limited potential.

Finally, completed TD 9s often precede either a multi-candle relief rally or sideways consolidation. If DOGE holds above $0.088–$0.090, it may reach $0.105–$0.112 during the next mean reversion phase. 

Consequently, statistical timing indicates that downside momentum is running out rather than signaling hype-driven strength.

Macro Accumulation Zone Suggests Long-Term Upside On the monthly chart, DOGE trades within a macro accumulation range of $0.077–$0.055. This zone follows a deep correction from its all-time high and marks a re-accumulation phase. 

$DOGE ALTSEASON SETUP | 400%–900% MACRO UPSIDE POTENTIAL#DOGE is trading into Monthly HTF demand after completing a full macro drawdown from ATH, placing price inside a re-accumulation zone.

Technical Structure
✅ Macro correction completed
✅ Extended HTF accumulation range… pic.twitter.com/TExGWGoJhP

— Crypto Patel (@CryptoPatel) February 6, 2026

Down ~89% from ATH, DOGE remains in extended high-timeframe demand. Furthermore, phased accumulation is recommended over lump-sum entries. 

Pullbacks into $0.077–$0.070, combined with shifts in low-timeframe structure, provide higher-probability setups. Conversely, a monthly close below $0.055 would invalidate the long-term thesis.

Additionally, liquidity targets indicate potential upside. Price could test $0.156, $0.306, $0.48, and eventually $1 if monthly support holds. 

Therefore, the macro accumulation zone combined with the TD Sequential buy setup signals that the market may quietly reset for the next upward move.

Ultimately, DOGE’s short-term relief bounce aligns with longer-term accumulation dynamics. Price stabilization, improving momentum, and statistical exhaustion suggest that the current levels offer a risk-reward opportunity for both swing and long-term positions.

Bitcoin’s hard cap is easy to understand: there will only ever be 21 million coins.

What's hard to understand is that the marginal market is allowed to trade far more than 21 million coins worth of exposure, because most of that exposure is synthetic and cash-settled, and it can be created or reduced in seconds.

That distinction has become Bitcoin's core paradox in the past year or so.

Scarcity is a property of the asset, while price is a property of the market microstructure that dominates the next aggressive order. When derivatives volume and leveraged positioning become the dominant arena, Bitcoin can trade like an asset with a tight supply and, at the same time, like an asset with effectively elastic exposure.

21 million coins, but a much larger marginal marketSpot is the only venue where a trade necessarily moves actual BTC from one owner to another.

Perpetual and dated futures don't mint coins, but they do create a second market that can become larger, faster, and more reflexive than spot. Perps are designed to track spot through a funding mechanism and can be traded with leverage, which means a relatively small amount of collateral can control a much larger notional position. That combination tends to pull activity into derivatives when traders want speed, leverage, shorting ability, and capital efficiency.

Price discovery is simply where the next meaningful market order lands. If most urgency lives in perps, then the path of least resistance is set there, even if long-term holders never touch leverage and even if the underlying supply is fixed. In that regime, moves are frequently driven by changes in positioning: liquidations, forced de-risking, hedging flows, and the rapid repricing of leverage. Those flows can overwhelm the much slower process of spot accumulation, because the marginal actor isn't choosing whether to buy coins but whether to add or reduce exposure.

This is also why visible order book support is a weaker concept than it looks on a chart. Displayed bids can be real, but they're conditional. They can be pulled, layered, refreshed, or simply outpaced by the volume coming from the larger derivatives complex. Order books are records of resting intent, not execution guarantees.

What the data showsThe Binance BTC/USDT perpetual futures versus spot volume ratio is the cleanest starting point because it quantifies where activity is concentrated.

On Feb. 3, the perpetual-to-spot volume ratio read 7.87, with $23.51 billion in perpetual volume against $2.99 billion in spot while BTC traded around $75,770. On Feb. 5, the ratio was still 6.12, with $15.97 billion in perps volume against $2.61 billion in spot, and the price near $69,700.

The ratios matter because they're not a minor skew; they describe a market where the dominant source of turnover is a leveraged, shortable venue. In that setup, the next tick is more likely to be set by the repricing of exposure than by incremental spot buying.

The aggregated order book liquidity delta adds a second layer: not just where volume traded, but where liquidity accumulated near price. CoinGlass defines depth delta as the imbalance between bids and asks within a specified range, here ±1% around the current price, which is a way to summarize whether the visible book is bid-heavy or offer-heavy.

The biggest footprint appears on the derivatives side right as the market was entering the drawdown window. Futures liquidity delta printed +$297.75 million on Jan. 31 at 14:00 with BTC around $82,767. Spot later showed +$95.32 million at 18:00 around $78,893. Even by Feb. 5 at 14:00, spot delta still showed +$36.66 million with BTC near $69,486.

This data shows a market where spot bids existed and, in some moments, grew, but price still kept sliding. Once you accept the hierarchy where derivatives are the dominant class, this stops being a contradiction. Displayed liquidity near spot can improve while the larger derivatives venue continues to force repricing through leverage reduction, short pressure, or hedging. When perps dominate turnover, the marginal seller isn't a real person that's lost conviction, it's just a manager managing positions.

Now add the third channel that investors tend to treat as the definitive spot proxy: US spot Bitcoin ETFs. The flow sequence we've seen in last week looks like a tug-of-war rather than a steering wheel aimed at the cliff.

Heavy outflows hit on Jan. 21 at about -$708.7 million, then Jan. 29 at about -$817.8 million, then Jan. 30 at about -$509.7 million. Feb. 2 flipped sharply positive at about +$561.8 million, then reverted to -$272.0 million on Feb. 3 and -$544.9 million on Feb. 4.

Public flow tallies like these are widely tracked through aggregators such as Farside and are frequently referenced in market coverage, but they fail map one-for-one to intraday price when the derivatives venue is setting the marginal trade.

It's also worth being precise about what an ETF flow is and is not. Creations and redemptions are executed through authorized participants. Depending on the product and regulatory permissions, those processes can be cash-based or in-kind, which changes how directly ETF activity translates into spot market transactions in BTC.

In mid-2025, the SEC approved orders permitting in-kind creations and redemptions for crypto ETPs, which is specifically about allowing authorized participants to create or redeem shares using the underlying crypto rather than only cash, bringing the operational structure closer to other commodity ETPs. (SEC) Even with that structure, ETF flows still sit alongside derivatives positioning, dealer hedging, and exchange liquidity, which can dominate short-horizon price formation.

CryptoSlate Daily Brief

Daily signals, zero noise.Market-moving headlines and context delivered every morning in one tight read.

5-minute digest 100k+ readers

Free. No spam. Unsubscribe any time.

You’re subscribed. Welcome aboard.

Finally, exchange reserve data anchors this abstract data into something more tangible: the amount of BTC sitting on exchanges, which is a proxy for immediately tradable inventory.

From Jan. 15 to Feb. 5, all-exchange BTC reserves rose by 29,048 BTC, a 1.067% increase, reaching just over 2.75 million BTC.

This matters because it separates two ideas that are often blended together.

Bitcoin can be scarce in total supply and still feel well supplied at the point of transaction if exchange inventory rises into a risk-off window. ETF inflows can be positive and yet the tradable float can expand via deposits, treasury moves, or repositioning by large holders. And even if the tradable float tightens, derivatives can still amplify volatility because exposure can be added or removed faster than coins can move.

A scarcity model that matches how Bitcoin tradesA useful way to reconcile all of this is to treat Bitcoin scarcity as a stack of time horizons rather than a single number.

At the slowest layer is protocol supply, which is fixed by design. That's the layer the 21 million cap describes.

At the middle layer is the tradable float, which is what can realistically hit the market without friction. Exchange reserves aren't the best proxy for this, but they're directionally useful because they measure coins that are already sitting on a platform built for rapid transaction.

At the fast layer is the synthetic exposure: perps, dated futures, and options. This layer can expand or contract extremely quickly because it's constrained by collateral and risk limits, not by coin movement. When activity concentrates here, a large share of the market is expressing views through leverage and hedges, not through coin acquisition.

At the final layer is the marginal trade itself: the next forced buy or sell that clears through the most active venue. The perpetual-to-spot volume ratios that have been sitting between roughly 6 and 8, combined with the larger liquidity delta prints on futures, show a market where that marginal trade was happening in derivatives, not in spot.

That framing tells us that scarcity is real, but it doesn't guarantee day-to-day tightness. The market can trade scarce assets through abundant exposure, and the venue with the most urgent flow tends to set the next price.

That's why we need to treat ETF flows, exchange reserves, and derivatives dominance as three separate lenses that can disagree in the short run. When they line up, moves tend to be cleaner. When they diverge, you can see exactly what the charts show: bids appear, narratives whip around, and price still bleeds because the marginal market is elsewhere.

Mentioned in this articlePosted in

18h17 ▪ 4 min read ▪ by Eddy S.

Summarize this article with:

Ethereum has just suffered a spectacular 40% drop, reminiscent of the brutal corrections of 2025. While some investors panic, Tom Lee sees it as a unique buying opportunity. Between macroeconomic uncertainties and technological potential, this decline is dividing the crypto market.

In Brief Ethereum’s 40% fall in 2026 is explained by macroeconomic uncertainties, negative flows in ETFs, and correlation with bitcoin. Tom Lee compares this drop to that of 2025, followed by a +300% rebound, and highlights Ethereum network’s long-term potential. Investment strategies vary: spot buying, DCA or options, but risks remain if economic conditions worsen. Crypto: Why is Ethereum Falling by 40%? Ethereum is currently showing a 40% decline explained by several factors. First, the persistent macroeconomic uncertainty with tensions around Fed decisions and inflation. Then, Ethereum suffers from its correlation with bitcoin, whose fall triggered a wave of sales across the crypto sector.

Finally, negative flows in Ethereum ETFs have also increased the pressure. According to data from CoinShares, Ethereum-linked products recorded massive outflows, reflecting institutional investors’ distrust. This combination of factors led to a brutal correction, but some see it as a simple adjustment before a broader recovery.

The current collapse of Ethereum strangely recalls that of 2025. At that time, Ethereum had a similar drop before rebounding by more than 300%. Tom Lee, an influential figure in the crypto ecosystem, points out that this dynamic could repeat. According to him, the Ethereum network continues to gain traction, especially due to the growing adoption of smart contracts and decentralized applications.

Options market data confirms this thesis from Tom Lee. Indeed, investors are betting on key levels, such as 2,150 dollars or 2,200 dollars, by mid-February, while anticipating a possible low at 1,700 dollars. This duality reflects a divided market, but the fundamentals remain solid. Analysts note that corrections of this magnitude have often preceded major rallies.

Should You Buy Ethereum Now? Strategies and Risks Investing in Ethereum today requires a thoughtful approach. Strategies vary depending on risk profile. Some prefer spot buying, betting on a gradual rise. Others opt for Dollar-Cost Averaging (DCA), a method allowing risk smoothing by investing regularly, regardless of the price.

Additionally, options remain an alternative for experienced investors. However, risks persist because a new drop is not to be excluded, especially if macroeconomic conditions deteriorate. Experts therefore recommend not investing more than one can afford to lose and diversifying one’s portfolio.

Ethereum is going through a critical phase, but opportunities are plenty for those who know how to seize them. Between historical parallels and technological innovations, this drop could mark the beginning of a new bullish cycle according to Tom Lee. And you, do you see in this drop of ETH an opportunity to seize or a warning sign?

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

Eddy S.

The world is evolving and adaptation is the best weapon to survive in this undulating universe. Originally a crypto community manager, I am interested in anything that is directly or indirectly related to blockchain and its derivatives. To share my experience and promote a field that I am passionate about, nothing is better than writing informative and relaxed articles.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.

Trusted Editorial content, reviewed by leading industry experts and seasoned editors. Ad Disclosure

The Bitcoin price has been on one of its worst runs in recent years, falling by double digits over the past week. While the premier cryptocurrency seems to be recovering well over the past day, the single-day 14% correction — on Thursday, February 5 — is an occurrence that has instilled fear in the market, and rightly so. In their latest report, a renowned pundit has tried to come up with answers to the questions currently swirling around the Bitcoin price.

Crypto Bear Markets End In Exhaustion, Not Excitement — Bitwise CIO On Friday, February 6, Bitwise’s Chief Investment Officer, Matt Hougan, answered questions the about the current structure and outlook for the Bitcoin price. The senior executive wrote about why the market is down, if it would fall further, and what would help the BTC price reach a bottom.

Hougan started by noting that there is never a single reason why the crypto market fell, as multiple factors are often at play. In this latest correction, the Bitwise CIO listed about six contributing factors, including front-running the four-year cycle, the loss of “attention investor” to AI and metals, and the infamous October 10 liquidation event.

It is important to note that the market and the Bitcoin price action has not been the same since the significant leveraged blowout on October 10, 2025. This historical liquidation event came off the back of United States President Donald Trump announcing a surprise 100% tariff on all Chinese goods.

Other factors highlighted in the Bitwise’s report include concerns around Kevin Warsh as Federal Reserve chair, quantum computing fears, and macro risk-off sentiment. Notably, it could be said that Bitcoin and the crypto market are not the only victims of this sentiment shift, as mineral and stock markets have also seen significant declines.

Hougan mentioned the good news is that the sell-off signs appears to be showing signs of exhaustion.

The Bitwise CIO wrote:

According to onchain data, long-term holders have stopped selling aggressively, and some are beginning to nibble around the edges. Open interest on bitcoin derivatives exchanges has fallen to levels last seen in 2024.

Hougan went on to say that, if history is to go by, it is possible for the Bitcoin price to fall further in the current structure. However, the investment expert also believes that premier cryptocurrency is a more mature asset, and is less likely to see a 77% correction as in the past.

While he could not pinpoint the exact time the Bitcoin price would reach a bottom, the Bitwise CIO revealed that the catalyst that could turn things around is simply time. “Crypto bear markets tend to end in exhaustion, not excitement,” Hougan concluded.

Bitcoin Price At A Glance As of this writing, the price of BTC stands at around $67,834, reflecting an over 4% jump in the past 24 hours.

The price of BTC on the daily timeframe | Source: BTCUSDT chart on TradingView Featured image from iStock, chart from TradingView

Editorial Process for bitcoinist is centered on delivering thoroughly researched, accurate, and unbiased content. We uphold strict sourcing standards, and each page undergoes diligent review by our team of top technology experts and seasoned editors. This process ensures the integrity, relevance, and value of our content for our readers.

Story HighlightsThe live price of the CRV token is  $ 0.25757634.Price predictions for 2026 range from $0.45 to $3.00.Curve Dao (CRV) could extend toward $8.00 by 2030, if recovery structure holds.Curve DAO (CRV) is entering a technically sensitive phase where its role as a core DeFi liquidity protocol contrasts sharply with a price structure that has spent months compressing near long-term support. With 2026 already underway, CRV’s price behavior is no longer defined by aggressive downside extensions but by controlled ranges, contracting volatility, and repeated defenses of demand conditions that often precede a broader trend transition.

Fundamentally, Curve continues to sit at the center of decentralized liquidity infrastructure, particularly across stablecoin and low-slippage markets. While price action has lagged this relevance, the technical structure is beginning to reflect stabilization rather than decay. As the first quarter of 2026 unfolds, the market is closely watching whether this prolonged consolidation evolves into a sustained recovery phase or remains range-bound for longer.

CryptocurrencyCurve DAO TokenTokenCRVPrice$0.2576 -1.81% Market Cap$ 376,737,431.2424h Volume$ 85,822,875.6745Circulating Supply1,462,624,351.8103Total Supply2,350,361,338.7391All-Time High$ 60.4988 on 14 August 2020All-Time Low$ 0.1811 on 05 August 2024Curve Dao (CRV) Price February 2026 OutlookThrough February, CRV has continued to trade above its $0.22–$0.25 demand zone, a region that has repeatedly absorbed selling pressure since late 2025. Price remains compressed beneath overhead resistance near $0.35–$0.40, forming a tightening wedge on the daily timeframe.

This behavior suggests that bearish momentum is fading, even though bullish follow-through remains gradual. As long as CRV holds above its rising support trendline, downside risk appears limited. A decisive daily close above the $0.40 region would be a technical signal that accumulation is giving way to early expansion, while failure to break higher would likely extend consolidation without invalidating the broader setup.

Curve Dao (CRV) Price Prediction 2026As 2026 progresses, the focus shifts from whether CRV can hold its base to whether it can begin reclaiming higher structural levels. On higher timeframes, CRV appears to be forming a rounded accumulation zone following a multi-year downtrend, an environment typically associated with longer-term reversals rather than short-lived relief rallies.

If momentum gradually builds, CRV could start challenging intermediate resistance near $0.85, followed by the psychologically important $1.60 zone. These levels align with prior consolidation ranges and would likely attract profit-taking along the way. However, sustained acceptance above these areas could open a path toward the $2.40–$3.00 region before the end of 2026. Pullbacks toward $0.50–$0.65 would remain constructive as long as higher lows continue to form. A breakdown below long-term demand would delay the bullish outlook but would not automatically negate the broader recovery thesis unless followed by sustained weakness.

Curve Dao Crypto Price Prediction 2026 – 2030YearPotential Low ($)Potential Average ($Potential High ($)20260.451.753.0020271.502.004.5020282.104.106.0020293.406.007.2020304.806.508.00Curve Dao Price Prediction 2026In 2026, Curve Dao price could project a low price of $0.45, an average price of $1.75, and a high of $3.00.

Curve Dao Price Forecast 2027As per the Curve Dao Price Prediction 2027, Curve Dao may see a potential low price of $1.50 . Meanwhile, the average price is predicted to be around $2.00. The potential high for Curve Dao price in 2027 is estimated to reach $4.50.

Curve Dao (CRV) Price Prediction 2028In 2028, Curve Dao price is forecasted to potentially reach a low price of $2.10 and a high price of $6.00.

CRV Price Prediction 2029Thereafter, the Curve Dao  (Curve Dao) price for the year 2029 could range between $3.40 and $7.20.

Curve Dao Price Prediction 2030Finally, in 2030, the price of Curve Dao  is predicted to maintain a steady positive. It may trade between $4.80 and $8.00.

Curve Dao Price Prediction 2031, 2032, 2033, 2040, 2050The long-term projection assumes Curve Dao sustains relevance in enterprise blockchain use cases, with growth moderating over time as the asset matures.

YearPotential Low ($)Potential Average ($)Potential High ($)20315.207.409.0020326.008.6010.8020337.0011.5013.50204019.0025.0032.00205035.0048.0070.00Curve Dao (CRV) Price Prediction: Market Analysis?Year202620272030Changelly$2.40$3.80$6.50CoinCodex$1.90$3.50$7.00WalletInvestor$2.00$3.60$6.40CoinPedia’s Curve Dao Price PredictionCoinpedia’s price prediction for Curve DAO’s in 2026 and beyond hinges on whether its extended base structure transitions into sustained upside momentum. While CRV may not deliver rapid price acceleration, the current technical setup favors gradual recovery over continued decline. If broader DeFi sentiment improves and CRV maintains its higher-timeframe support zones, the token could steadily work toward multi-dollar valuations over the coming years. Failure to reclaim key resistance levels, however, would keep price action range-bound and delay the recovery cycle.

YearPotential Low ($)Potential Average ($)Potential High ($)20260.451.753.00Never Miss a Beat in the Crypto World!Stay ahead with breaking news, expert analysis, and real-time updates on the latest trends in Bitcoin, altcoins, DeFi, NFTs, and more.

FAQsWhat is the Curve DAO Token (CRV) used for?

Curve DAO Token (CRV) is used for governance, staking, and boosting rewards on Curve Finance, a leading DeFi protocol for low-slippage stablecoin trading.

What is the Curve DAO price prediction for 2026?

Curve DAO price prediction for 2026 suggests CRV may trade between $0.45 and $3.00 if long-term support holds and DeFi demand improves.

What is the CRV price prediction for 2030?

CRV price prediction for 2030 estimates a range between $4.80 and $8.00 if Curve continues serving as key liquidity infrastructure in DeFi.

What factors will influence Curve DAO price long term?

CRV’s long-term price depends on DeFi adoption, stablecoin growth, protocol revenue, governance activity, and broader crypto market cycles.

Disclaimer and Risk WarningThe price predictions in this article are based on the author's personal analysis and opinions. CoinPedia does not endorse or guarantee these views. Investors should conduct independent research before making any financial decisions.

The U.S. Securities and Exchange Commission (SEC) is accusing a California entrepreneur and his companies of executing a multi-million dollar Ponzi scheme.

The SEC says Satish Appalakutty and his businesses, Lorven Funds and Lorven Advisors LLC, drained $37 million from over 100 people.

Prosecutors say that between the start of 2019 through March 2024, Appalakutty solicited people from a Hindu temple and misrepresented how he would use potential investors’ funds.

He claimed he would use their cash to buy well-known stocks at a discounted price, purchase equity in private firms that have yet to launch initial public offerings (IPOs) or otherwise invest the funds in a way that would generate returns for the investor.

The SEC says Appalakutty falsely told the investors he would yield them minimum rates of 8% to 62.5% annually. However, instead of purchasing stocks, he used the money for his own personal benefit, to pay off other investors and to fund his software startup firm Vistalytics Inc.

The SEC has filed a civil complaint against Appalakutty and his entities in the U.S. District Court for the Northern District of California.

The charges allege violations of the antifraud provisions of the federal securities laws, specifically Section 17(a) of the Securities Act of 1933, Section 10(b) of the Securities Exchange Act of 1934, and Rule 10b-5 thereunder, for defrauding investors with false promises of high returns on fictitious investments.

The SEC is also looking to ban Apallakutty from acting as or being associated with any investment advice, fine him civil penalties and permanent injections against all defendants.

Generated Image: Midjourney

Tether Freezes $500 Million in Assets Linked to Turkish Gambling RingStablecoin issuer Tether froze more than $500 million in digital assets tied to an alleged illegal gambling and money-laundering network in Turkey.The firm's CEO Paolo Ardoino said the firm acted on information from law enforcement, underscoring Tether’s growing cooperation with agencies.Concurrently, the firm is leveraging its record $10 billion annual profit to diversify its massive USDT reserves into precious metals and Bitcoin mining.Tether, the issuer of the world’s most widely traded stablecoin, has frozen more than $500 million in digital assets.

The funds are linked to a massive illegal gambling and money-laundering syndicate in Turkey.

Sponsored

Sponsored

Tether Marks One of Crypto’s Largest CrackdownsThe freeze targets assets reportedly owned by Veysel Sahin, an individual Turkish prosecutors accuse of orchestrating a sprawling illegal betting network.

Notably, this move marks one of the largest single-asset seizures in the cryptocurrency sector to date.

Tether CEO Paolo Ardoino confirmed the company’s role in the crackdown, emphasizing the firm’s increasing cooperation with international law enforcement.

“Law enforcement came to us, they provided some information, we looked at the information and we acted in respect of the laws of the country. And that’s what we do when we work with the DOJ, when we work with the FBI, you name it,” he reportedly said.

Meanwhile, the enforcement action highlights a significant pivot for the British Virgin Islands-incorporated firm. Once criticized by regulators for a perceived lack of transparency, Tether has repositioned itself as a proactive partner to global police agencies.

Sponsored

Sponsored

Earlier this year, the company froze more than $180 million worth of its USDT token. In total, Tether has now frozen more than $3 billion in assets since its inception.

With a circulating supply exceeding $187 billion, Tether’s USDT token serves as the primary source of liquidity for the global cryptocurrency market. BeInCrypto previously reported that this asset serves more than 534 million users globally.

Its widespread use allows traders to move funds quickly between exchanges without relying on traditional banking rails.

However, the speed and scale of recent interventions have dismantled the “censorship-resistant” reputation that once defined the digital asset sector.

Beyond enforcement, Tether has been aggressively diversifying its USDT reserves over the past year.

The company recently announced a $150 million investment in Gold.com, and a $100 million strategic investment in Anchorage Digital, America’s first federally regulated digital asset bank.

Meanwhile, these investment follows a record-breaking financial year for the stablecoin giant.

Buoyed by $10 billion in 2025 profits, Tether has expanded its reach beyond stablecoins. The firm is now deploying capital across a diverse portfolio of internal initiatives, ranging from sports to Bitcoin mining, decentralized communications, and artificial intelligence.

Disclaimer

In adherence to the Trust Project guidelines, BeInCrypto is committed to unbiased, transparent reporting. This news article aims to provide accurate, timely information. However, readers are advised to verify facts independently and consult with a professional before making any decisions based on this content. Please note that our Terms and Conditions, Privacy Policy, and Disclaimers have been updated.

Dogecoin [DOGE] has drifted toward the lower boundary of its descending structure as a TD Sequential buy signal prints on the daily chart near $0.095. The signal appears after weeks of controlled selling rather than panic-driven liquidation. 

DOGE has spent months trending lower from its September peak, yet selling pressure has gradually lost intensity. Recent candles exhibit shorter bodies and slower follow-through, suggesting potential exhaustion. 

However, this signal does not invalidate the broader trend. Instead, it flags a potential pause or tactical rebound within a dominant downtrend. 

Therefore, the setup invites caution rather than optimism, especially while DOGE price remains below key resistance levels.

Downtrend structure still caps Dogecoin rebounds At press time, Dogecoin traded near $0.096 after rising roughly 6.3% over the past 24 hours, reflecting a reaction off structural support rather than a trend reversal. 

Dogecoin prices continue to follow a descending regression channel that has controlled movement for months. 

On the downside, the $0.080 zone remains the primary support, where previous selloffs stalled. Above the current price, $0.117 stands as the key resistance that has repeatedly rejected recovery attempts since November. 

Any sustainable rebound must reclaim this level first. Beyond it, $0.153 marks the next upside target aligned with prior distribution and the channel’s upper boundary.

Source: TradingView

Buyers stay active beneath the surface Spot Taker CVD remains buyer‑dominant despite prolonged price weakness.

Aggressive market buys continue to outweigh sells, showing demand is absorbing available supply rather than exiting. This contrasts sharply with panic selloffs, where CVD typically turns deeply negative.

Instead, DOGE shows steady bid absorption near local lows. However, buyers are not chasing prices higher. They are stepping in quietly as sellers lose urgency. 

Therefore, CVD supports the idea of accumulation through absorption rather than speculative momentum. 

This dynamic strengthens the relevance of the TD Sequential signal, since both point toward slowing downside pressure rather than immediate trend reversal.

Dogecoin exchange outflows hint at tightening supply Spot netflows reinforce this narrative. DOGE continues recording net-negative exchange flows, including a recent daily outflow of approximately $7.7 million as of writing. 

Tokens leaving exchanges during weakness suggest holders are not positioning for immediate distribution. 

Instead, sell-side availability appears to shrink near local lows. However, these flows do not yet confirm aggressive accumulation. 

They simply show reduced willingness to sell into weakness. Combined with buyer-dominant CVD, this trend limits downside acceleration unless new selling catalysts emerge. 

Therefore, while bearish structure persists, liquidity conditions no longer strongly favor sustained forced selling from current levels.

Leverage rebuilds near support, raising volatility risk At the time of writing, Open Interest (OI) climbed by over 5%, pushing total derivatives positioning to around $1.04 billion while price remains compressed.  This increase shows traders re-entering leverage near support rather than abandoning positions. 

However, rising OI without a structural breakout increases volatility risk instead of directional clarity. 

Both long and short positioning appear active, suggesting traders anticipate expansion rather than continuation. Therefore, the current zone carries heightened liquidation sensitivity. 

A decisive move beyond resistance or below support could trigger sharp, leverage-driven follow-through in either direction.

To conclude, Dogecoin’s TD Sequential buy signal aligns with channel exhaustion, buyer absorption, and reduced exchange supply, but the broader downtrend still dominates price structure. 

While conditions support a short-term stabilization or relief bounce, confirmation depends on DOGE reclaiming key channel levels. 

Until then, the setup favors volatility over conviction, with downside risk fading but not fully resolved.

Final Thoughts  Dogecoin’s current structure favors recovery attempts as accumulation replaces reactive selling near long-term support. A confirmed move above resistance would likely shift sentiment from defensive positioning toward trend continuation trades.

19h05 ▪ 4 min read ▪ by Eddy S.

Summarize this article with:

February 9, 2026, will mark a turning point for the crypto ecosystem with the official launch of MegaETH’s mainnet. Promising 100,000 transactions per second and ultra-low latency, this Layer 2 could redefine Ethereum’s standards. Here is how investors can maximize their points and anticipate a potential AirDrop.

In brief MegaETH activates its mainnet on February 9, 2026, with performance promising 100,000 transactions per second. To maximize your MegaETH points, bridge your ETH, participate in staking programs, and follow official announcements to accumulate rewards. MegaETH could reduce gas fees and boost the crypto ecosystem, offering opportunities to investors and developers. MegaETH switches to mainnet mode on February 9, 2026: what stakes for you? On February 9, 2026, MegaETH will activate its public mainnet, an event confirmed by the platform on X. This launch follows successful stress tests with over 10.7 billion transactions processed in one week, demonstrating a capacity of 100,000 transactions per second. Unlike other Layer 2 solutions like Arbitrum or Optimism, MegaETH stands out for its sub-millisecond latency, compatible with real-time demanding applications.

This project, backed by major figures like Vitalik Buterin, has raised hundreds of millions of dollars, attracting attention from crypto investors and developers. The goal is clear: solve Ethereum’s scalability issues while maintaining full compatibility with the EVM. For users, this means reduced fees, instant transactions, and a new era for dApps.

No confirmed Airdrop for MegaETH, but here are 5 concrete actions to take to maximize your chances:

First, bridge your ETH to MegaETH via the official bridge. This step is essential to access opportunities from day one; Second, engage in staking programs offered by platforms like Kumbaya. These initiatives allow you to accumulate points, which could be converted into future benefits;  Third, participate in community tests and activities on the network. These interactions increase your visibility and your chances of rewards; Fourth, monitor official announcements on MegaETH’s Twitter and Discord channels. Updates are shared in real time; Finally, beware of scams. Fake airdrops and phishing sites abound in the crypto ecosystem. Always verify the authenticity of sources before acting. MegaETH: a breakthrough that could explode Ethereum? The launch of MegaETH on February 9 is much more than a simple technological update. Indeed, as a scaling solution for Ethereum, its success could attract a significant portion of the network’s activity! Thus reducing gas fees and improving liquidity. Experts agree that if MegaETH reaches even 50% of its announced performance, it could boost the entire Ethereum ecosystem.

Furthermore, a massive adoption of MegaETH could lead to an increase in demand for ETH, thus strengthening its long-term value. However, risks remain, notably regarding centralization and regulation. Authorities could closely scrutinize this crypto project, especially if it becomes a dominant player.

The launch of MegaETH on February 9, 2026, could indeed be a pivotal moment for Ethereum and the entire crypto ecosystem. Between technological promises and challenges to overcome, the coming months will be decisive. For investors, the time to act is now: bridging, staking, and active participation will be the keys to profit from it.

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

Eddy S.

The world is evolving and adaptation is the best weapon to survive in this undulating universe. Originally a crypto community manager, I am interested in anything that is directly or indirectly related to blockchain and its derivatives. To share my experience and promote a field that I am passionate about, nothing is better than writing informative and relaxed articles.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.

The XRP price was on the verge of losing the $1 level merely two days ago, as the entire crypto market succumbed to an almost unprecedented level of volatility and bearish pressure. The altcoin fell to as low as $1.16, its lowest level since November 2024.

While the general cryptocurrency market appears to be showing some signs of recovery, the XRP price activity has been particularly impressive since bottoming out at around the $1.15 mark. According to a prominent crypto analytics firm, below are the reasons behind the altcoin’s latest resurgence.

Whale And Network Activity Throw XRP A Lifeline On Friday, February 6, popular blockchain firm Santiment took to the social media platform X to discuss the recent correction and the subsequent recovery experienced by the XRP price going into this weekend. With the strong volatility witnessed in the market, XRP seemed to be bound for $1 in that downward movement. 

Santiment said on X:

Panic sellers should have stopped to notice the massive activity on the XRP Ledger as speculators were discussing whether the coin would fall below $1.00.

However, the fourth-largest cryptocurrency by market capitalization briefly reclaimed the $1.5 level on Friday, signaling the return of fresh buying momentum to the market. According to Santiment, this XRP price jump might have been triggered by the group of large investors known as the whales.

The latest on-chain data shows that an “obvious” whale accumulation took place while the XRP price headed for the bottom. Santiment data shows that about 1,389 $100,000 whale transactions occurred during the dip, the highest volume seen over the past four months.

Source: @santimentfeed on X Meanwhile, activity on the XRP Ledger has been on the rise since the altcoin’s price fell to its lowest level in over a year. According to Santiment’s post on X, the amount of unique addresses on the blockchain saw a notable surge to 78,727 in just one 8-hour candle, its highest level in approximately six months.

The crypto analytics noted that these occurrences are both significant to the potential price resurgence of any asset. With an uptick in whale demand and network activity, the XRP price could build the foundation required to return to a bullish structure.

However, investors might want to approach the market with extreme caution, as a relief rally is not the strangest phenomenon in a bear market.

XRP Price At A Glance As of this writing, the price of XRP stands at around $1.46, reflecting an almost 25% jump in the past 24 hours. However, this single-day action is not enough to erase the past week’s losses, which still sit roughly over 16%.

The price of XRP on the daily timeframe | Source: XRPUSDT chart on TradingView Featured image from iStock, chart from TradingView

On Saturday, South Korean cryptocurrency exchange Bithumb faced a significant blunder, accidentally distributing over $40 billion worth of Bitcoins (CRYPTO: BTC) to customers during a promotional event. The exchange initially intended to give small cash rewards of 2,000 Korean won ($1.40) or more to each user, but instead, winners received at least 2,000 Bitcoins each, leading to a massive selloff.